These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 28483024)

  • 1. Preliminary Analysis of Parkinson-like Motor Coordination Abnormityin Brain-specific hS100B Transgenic Mice.
    Liu J; Zheng F; Long Y; Tong L; Zheng Y; Liu X; Qin C
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Apr; 39(2):240-246. PubMed ID: 28483024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S100B transgenic mice develop features of Parkinson's disease.
    Liu J; Wang H; Zhang L; Xu Y; Deng W; Zhu H; Qin C
    Arch Med Res; 2011 Jan; 42(1):1-7. PubMed ID: 21376255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabonomics study of brain-specific human S100B transgenic mice by using high-performance liquid chromatography coupled with quadrupole time of flight mass spectrometry.
    Liu JL; Wang HL; Zhang LF; Xu YF; Deng W; Zhu H; Qin C
    Biol Pharm Bull; 2011; 34(6):871-6. PubMed ID: 21628886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral deficits and striatal DA signaling in LRRK2 p.G2019S transgenic rats: a multimodal investigation including PET neuroimaging.
    Walker MD; Volta M; Cataldi S; Dinelle K; Beccano-Kelly D; Munsie L; Kornelsen R; Mah C; Chou P; Co K; Khinda J; Mroczek M; Bergeron S; Yu K; Cao LP; Funk N; Ott T; Galter D; Riess O; Biskup S; Milnerwood AJ; Stoessl AJ; Farrer MJ; Sossi V
    J Parkinsons Dis; 2014; 4(3):483-98. PubMed ID: 25000966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Commentary on "Novel Interaction of the Dopamine D2 Receptor and the Ca
    Lee HJ; Rodriguez-Contreras D; Neve KA
    Mol Pharmacol; 2021 Aug; 100(2):61-64. PubMed ID: 34045267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered Expression of D1 and D2 Dopamine Receptors in Vagal Neurons Innervating the Gastric Muscularis Externa in a Parkinson's Disease Rat Model.
    Wang ZY; Lian H; Zhou L; Zhang YM; Cai QQ; Zheng LF; Zhu JX
    J Parkinsons Dis; 2016 May; 6(2):317-23. PubMed ID: 27164043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging role of S100B protein implication in Parkinson's disease pathogenesis.
    Angelopoulou E; Paudel YN; Piperi C
    Cell Mol Life Sci; 2021 Feb; 78(4):1445-1453. PubMed ID: 33052436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of dopamine D2 and D4 receptor and tyrosine hydroxylase mRNA in mice prone, or resistant, to chronic high-fat diet-induced obesity.
    Huang XF; Yu Y; Zavitsanou K; Han M; Storlien L
    Brain Res Mol Brain Res; 2005 Apr; 135(1-2):150-61. PubMed ID: 15857678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered expression of dopamine receptors in cholinergic motoneurons of the hypoglossal nucleus in a 6-OHDA-induced Parkinson's disease rat model.
    Zhou L; Wang ZY; Lian H; Song HY; Zhang YM; Zhang XL; Fan RF; Zheng LF; Zhu JX
    Biochem Biophys Res Commun; 2014 Sep; 452(3):560-6. PubMed ID: 25172664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain infusion of α-synuclein oligomers induces motor and non-motor Parkinson's disease-like symptoms in mice.
    Fortuna JTS; Gralle M; Beckman D; Neves FS; Diniz LP; Frost PS; Barros-Aragão F; Santos LE; Gonçalves RA; Romão L; Zamberlan DC; Soares FAA; Braga C; Foguel D; Gomes FCA; De Felice FG; Ferreira ST; Clarke JR; Figueiredo CP
    Behav Brain Res; 2017 Aug; 333():150-160. PubMed ID: 28668282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G-protein coupled receptor 6 deficiency alters striatal dopamine and cAMP concentrations and reduces dyskinesia in a mouse model of Parkinson's disease.
    Oeckl P; Hengerer B; Ferger B
    Exp Neurol; 2014 Jul; 257():1-9. PubMed ID: 24747358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced striatal dopamine DA D2 receptor function in dominant-negative GSK-3 transgenic mice.
    Gomez-Sintes R; Bortolozzi A; Artigas F; Lucas JJ
    Eur Neuropsychopharmacol; 2014 Sep; 24(9):1524-33. PubMed ID: 25088904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine receptor agonists reverse behavioral abnormalities of alpha-synuclein transgenic mouse, a new model of Parkinson's disease.
    Wakamatsu M; Iwata S; Funakoshi T; Yoshimoto M
    J Neurosci Res; 2008 Feb; 86(3):640-6. PubMed ID: 17896793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring Interactions Between S100B and the Dopamine D2 Receptor Using NMR Spectroscopy.
    Wang Y; Tadayon R; Shaw GS
    Methods Mol Biol; 2019; 1929():311-324. PubMed ID: 30710282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S100B interacts with the serotonin 5-HT7 receptor to regulate a depressive-like behavior.
    Stroth N; Svenningsson P
    Eur Neuropsychopharmacol; 2015 Dec; 25(12):2372-80. PubMed ID: 26499172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic rewiring of neural circuits in the motor cortex in mouse models of Parkinson's disease.
    Guo L; Xiong H; Kim JI; Wu YW; Lalchandani RR; Cui Y; Shu Y; Xu T; Ding JB
    Nat Neurosci; 2015 Sep; 18(9):1299-1309. PubMed ID: 26237365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of rimonabant, a selective cannabinoid CB1 receptor antagonist, in a rat model of Parkinson's disease.
    González S; Scorticati C; García-Arencibia M; de Miguel R; Ramos JA; Fernández-Ruiz J
    Brain Res; 2006 Feb; 1073-1074():209-19. PubMed ID: 16412990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine D3 receptor is decreased and D2 receptor is elevated in the striatum of Parkinson's disease.
    Ryoo HL; Pierrotti D; Joyce JN
    Mov Disord; 1998 Sep; 13(5):788-97. PubMed ID: 9756147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel interaction of the dopamine D2 receptor and the Ca2+ binding protein S100B: role in D2 receptor function.
    Liu Y; Buck DC; Neve KA
    Mol Pharmacol; 2008 Aug; 74(2):371-8. PubMed ID: 18445708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic inactivation of dopamine D1 but not D2 receptors inhibits L-DOPA-induced dyskinesia and histone activation.
    Darmopil S; Martín AB; De Diego IR; Ares S; Moratalla R
    Biol Psychiatry; 2009 Sep; 66(6):603-13. PubMed ID: 19520364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.